Ascendis Pharma Yönetim

Yönetim kriter kontrolleri 2/4

Ascendis Pharma CEO'su Jan Mikkelsen, Dec2007 tarihinde atandı, in görev süresi 16.92 yıldır. şirketin hisselerinin 0.71% doğrudan sahiptir ve bu hisselerin değeri $ 54.23M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 8.3 yıl ve 6.8 yıldır.

Anahtar bilgiler

Jan Mikkelsen

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi16.9yrs
CEO sahipliği0.7%
Yönetim ortalama görev süresi8.3yrs
Yönetim Kurulu ortalama görev süresi6.8yrs

Son yönetim güncellemeleri

Recent updates

Ascendis Pharma Takes A Big Price Cut On Skytrofa

Sep 05

Ascendis Pharma A/S' (NASDAQ:ASND) Share Price Could Signal Some Risk

Jul 20
Ascendis Pharma A/S' (NASDAQ:ASND) Share Price Could Signal Some Risk

Some Confidence Is Lacking In Ascendis Pharma A/S' (NASDAQ:ASND) P/S

Apr 05
Some Confidence Is Lacking In Ascendis Pharma A/S' (NASDAQ:ASND) P/S

Ascendis Pharma's Ambitious Vision 2030

Jan 11

What Ascendis Pharma A/S' (NASDAQ:ASND) 29% Share Price Gain Is Not Telling You

Dec 21
What Ascendis Pharma A/S' (NASDAQ:ASND) 29% Share Price Gain Is Not Telling You

Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Nov 10
Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Ascendis Pharma A/S' (NASDAQ:ASND) Popularity With Investors Is Under Threat From Overpricing

Oct 05
Ascendis Pharma A/S' (NASDAQ:ASND) Popularity With Investors Is Under Threat From Overpricing

Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Jun 27
Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Analysts Are Betting On Ascendis Pharma A/S (NASDAQ:ASND) With A Big Upgrade This Week

May 05
Analysts Are Betting On Ascendis Pharma A/S (NASDAQ:ASND) With A Big Upgrade This Week

Is Ascendis Pharma (NASDAQ:ASND) Using Debt In A Risky Way?

Feb 18
Is Ascendis Pharma (NASDAQ:ASND) Using Debt In A Risky Way?

Is Ascendis Pharma (NASDAQ:ASND) A Risky Investment?

Sep 24
Is Ascendis Pharma (NASDAQ:ASND) A Risky Investment?

Ascendis Pharma: TransCon CNP Data Coming Q4

Sep 15

Ascendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTH

Aug 31

Ascendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug Skytrofa

Aug 11

Ascendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain Prospect

Aug 03

Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money

Jun 10
Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money

CEO

Jan Mikkelsen (64 yo)

16.9yrs

Görev süresi

Mr. Jan Moller Mikkelsen serves as the Chief Executive Officer, President, Executive Director and Member of Executive Board of Ascendis Pharma A/S since December 2007. He is Director at Eyconis, Inc. He se...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jan Mikkelsen
President16.9yrsVeri yok0.71%
$ 54.2m
Scott Smith
CFO, Executive VP & Member of Executive Board8.3yrsVeri yok0.0067%
$ 514.6k
Lotte Sonderbjerg
Executive VP16.9yrsVeri yok0.0031%
$ 238.1k
Michael Jensen
Executive VP11.4yrsVeri yok0.0032%
$ 247.3k
Mads Bodenhoff
Senior VP of Finance & Principal Accounting Officerless than a yearVeri yokVeri yok
Timothy Lee
Senior Director of Investor Relationsno dataVeri yokVeri yok
Flemming Jensen
Executive Vice President of Product Supply & Quality9.3yrsVeri yok0.0031%
$ 238.1k
Kennett Sprogoe
Executive VP and Head of Research & Product Development8.8yrsVeri yok0.0048%
$ 369.8k
Stina Singel
Executive VP & Head of Clinical Development for Oncology2.8yrsVeri yokVeri yok
Joseph Kelly
Head of U.S. Commercial of Endocrinology2.5yrsVeri yokVeri yok
Scott Holmes
Head of Global Commercial Strategy of Endocrinology2.5yrsVeri yokVeri yok
Camilla Hartvig
Executive VP & Global Chief Commercial Officer1.4yrsVeri yokVeri yok

8.3yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: ASND 'un yönetim ekibi deneyimli ve deneyimlidir ( 8.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jan Mikkelsen
President16.9yrsVeri yok0.71%
$ 54.2m
Albert Cha
Independent Chairman10yrs€139.72k0.00065%
$ 49.8k
William Fairey
Independent Director2.2yrs€73.01k0%
$ 0
Lisa Morrison
Independent Director7.6yrs€92.64k0.00065%
$ 49.8k
Lars Holtug
Independent Director6yrs€96.17k0.0015%
$ 114.1k
Siham Imani
Independent Director2.2yrs€69.48k0%
$ 0

6.8yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ASND 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).